Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 810-816-6 | CAS number: 1473386-36-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
Test material
- Reference substance name:
- heptadecyl (branched) acrylate
- EC Number:
- 810-816-6
- Cas Number:
- 1473386-36-5
- Molecular formula:
- C20H38O2
- IUPAC Name:
- heptadecyl (branched) acrylate
- Reference substance name:
- C17 Acrylate
- IUPAC Name:
- C17 Acrylate
- Details on test material:
- - Name of test material (as cited in study report): C 17 Acrylate
- Physical state: liquid/colorless, clear
- Analytical purity: 96.2 %
- Lot/batch No.: S731910108
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Germany
- Age at study initiation: Young adult animals (male animals approx. 8 weeks, female animals approx. 12 weeks)
- Weight at study initiation: Animals of comparable weight (± 20% of the mean weight, actual weights)
- Housing: Makrolon cage, type III, Single housing
- Diet (e.g. ad libitum): VRF1(P); SDS Special Diets Services, 67122 Altrip, Germany
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: at least 5 days before the beginning of the experimental phase
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C +/- 3°C
- Humidity (%): 30 - 70%
- Air changes (per hr): approx. 10
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 40 cm²
- % coverage: 10
- Type of wrap if used: air-permeable dressing (4 layers of absorbent gauze (Ph. Eur. supplied by Lohmann GmbH & Co., KG) and stretch bandage (Fixomull® Stretch (adhesive fleece) supplied by Beiersdorf AG)
REMOVAL OF TEST SUBSTANCE
- Washing (if done): Afterwards removal of the semi-occlusive dressing, rinsing of the application site with warm water
- Time after start of exposure: 24 h - Duration of exposure:
- 24 h
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Details on study design:
- - Duration of observation period following administration: 14 days
- Other examinations performed: clinical signs, body weight, pathology
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- No mortality occurred during the observation period.
- Clinical signs:
- No systemic clinical signs were observed during clinical examination.
In all male animals well-defined erythema (grade 2) was observed on study day 1 and persisted in 3 males until study day 3. In two animals moderate erythema (grade 3) was noticed on study day 2 and 3 after application. On study day 6 very slight erythema (grade 1) was observed in all male animals and persisted in three of these animals until study day 7 or 8.
Slight edema (grade 2) was noted in all animals on study day 1 and persisted until study day 2 or 3 in three animals. Slight edema increased to moderate edema (grade 3) in two animals on study day 3 or in one animal from day 2 until day 3. On study day 6 very slight edema (grade 1) was observed in two male animals. From study day 6 until study day 7, 13 or 14 incrustations were noted in three animals.
Scaling was observed on study day 6 in four animals and persisted in these animals up to study day 10 or 14. In one male scaling was seen on study day 7 only.
In all female animals well-defined erythema (grade 2) was noticed on study day 1 and persisted in four animals until study day 3. Moderate erythema (grade 3) was seen in one animal on study 2 and 3. Very slight erythema (grade 1) was noted in all females on study day 6 and persisted in two of these females until study day 7 or 8.
Slight edema (grade 2) was seen in all female animals from study day 1 until study day 3, while very slight edema (grade 1) was observed on study day 6 in two animals.
Incrustations were observed in one animal from study day 2 until study 7 and from study day 13 until study day 14, while in another animal these finding was observed from study day 6 until study day 14. In a third female animal incrustations were observed from study day 8 until study 10, while a fourth female showed incrustations on study day 13 and 14.
Scaling was observed in all animals from study day 6, 7 or 8 until study day 10 or 14, respectively. - Body weight:
- The mean body weight of the male animals increased within the normal range throughout the study period.
The body weight of two female animals adequately increased throughout the study period. The body weight of another female stagnated during the first week, while the body weight of fourth animal stagnated during the second week. A fifth animal showed marginally body weight loss during the first week and only a slight increase in weight during the second week. - Gross pathology:
- No macroscopic pathologic abnormalities were noted in the animals (5 males and 5 females) examined on the last day of observation.
Any other information on results incl. tables
Mortality |
||
Dose (mg/kg bw): |
5000 |
5000 |
Sex: |
female |
male |
Administration: |
1 |
1 |
No. of animals |
5 |
5 |
Mortality (animals): |
No mortality |
No mortality |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study the median lethal dose (LD50) of C 17 Acrylate after dermal application was found to be greater than 5000 mg/kg bw in male and female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.